Different types of insulin therapeutic regimens (ITRs) have also been associated with overweight/obesity, as observed in the Diabetes Control and Complications Trial (DCCT) where the use of intensive insulin therapy was closely associated with weight gain [8, 9]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.